<p>Jeannie Hoffman-Censits discusses her randomized phase 2 adding SG to maintenence avelumab in mUC.</p>

Episode 422: ACSO 2025 - ctDNA data from NIAGARA

Broadcasting the latest developments in GU cancer

Hosted by Brian Rini and Tom Powles 

Brian Rini MD is an Ingram Professor of Medicine (Hematology/Oncology), Vanderbilt-Ingram Cancer Center
Tom Powles is the Director of Barts Cancer Centre, St Bartholomew's Hospital and Professor of Genitourinary Oncology, Queen Mary University of London